Food News and Research

RSS

Great Point and Deerfield invest in BioSante Pharmaceuticals

BioSante Pharmaceuticals, Inc. today announced the closing of the sale, directly to funds affiliated with two institutional investors, of an aggregate of approximately 10.4 million shares of BioSante’s common stock and warrants to purchase up to approximately 5.2 million shares of its common stock, resulting in gross cash proceeds to BioSante of $18 million.

11 Mar 2010

Evotec completes first-in-human Phase I study of EVT 103 for treatment-resistant depression

Evotec AG today announced two positive aspects that strengthen its integrated product development in treatment-resistant depression in its strategic alliance with Roche.

11 Mar 2010

Bioness announces two agreements to distribute new devices for patients with neurological impairment

Bioness Inc., a leading neuromodulation company, announced today two agreements to distribute new devices for patients experiencing neurological impairment. Through the agreements with Performance Enterprises and Aretech™, LLC, Bioness is now distributing the Dynavision D2™ Visuomotor Training System and the ZeroG™ Overground Gait and Balance Training System to rehabilitation centers and hospitals.

11 Mar 2010

Controlling cholesterol using biologically active molecules isolated from algal infusion

Researchers at Wayne State University's Department of Nutrition and Food Science believe they've uncovered a unique method to control and regulate cholesterol using biologically active molecules isolated from ProAlgaZyme™ -- a proprietary algal infusion produced by Health Enhancement Products, Inc., of Scottsdale, Arizona.

11 Mar 2010

Lotus Pharmaceuticals announces groundbreaking ceremony to construct new building complex in Beijing

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China, reported the groundbreaking ceremony on March 9 to construct a new building complex on the grounds of its production facility in Beijing.

11 Mar 2010

Quantum Polymers offers AvaSpire modified PEEK resin based plastic products

Quantum Polymers today announced the availability of extruded stock shape plastic products made with AvaSpire® resin from Solvay Advanced Polymers (Alpharetta, Ga.). AvaSpire is a modified polyetheretherketone (PEEK) resin that has been formulated to offer improved ductility, mechanical strength and higher operating temperature relative to PEEK while retaining most of the key performance attributes of PEEK at a lower price point.

11 Mar 2010

Congress works on tariff-lowering legislation for Haiti as Preval meets with U.S. leaders in Washington

The Senate Finance Committee's chair, Max Baucus (D-Mont.), and top Republican, Charles Grassley (Iowa), are working with colleagues in the House on legislation that would lower tariffs in an effort to help Haiti's apparel industry and help the country recover from the major January earthquake, CQ Politics reports.

11 Mar 2010

Global Food Security: New programme aims at providing sustainable, secure supply of good quality food

The UK's main public funders of food-related research and training will today (11 March) join together to launch a new programme aimed at meeting the challenge of providing the world's growing population with a sustainable, secure supply of good quality food using less land and fewer resources. The organisations will work together through a new programme - Global Food Security - to coordinate and align their research interests.

11 Mar 2010

QLT announces results from Phase II clinical trials and device study for PPDS

QLT Inc. today announced results from Phase II clinical trials and a device study for the punctal plug delivery system (PPDS). These studies are part of a development program that is being conducted by QLT's wholly-owned subsidiary, QLT Plug Delivery, Inc. QLT also announced its plans to expand the program to evaluate a second drug for a new target indication.

11 Mar 2010

Patients who undergo gastric bypass surgery increase their risk of developing kidney stones

Patients who undergo gastric bypass surgery experience changes in their urine composition that increase their risk of developing kidney stones, research from UT Southwestern Medical Center investigators suggests.

10 Mar 2010

DSPA's lurasidone NDA accepted for FDA review

Dainippon Sumitomo Pharma America, Inc., a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd., today announced that the U.S. Food and Drug Administration recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. The NDA was submitted to FDA on December 30, 2009 and will receive a standard review.

10 Mar 2010

Biomoda, Obio collaborate to expand Biomoda’s lung cancer screening program for veterans into Ohio

Cancer diagnostics company Biomoda, Inc. (www.biomoda.com) and Obio, Inc., a corporation formed to pursue public and private funding for cancer research in Ohio, are working together to expand Biomoda’s lung cancer screening program for veterans into Ohio.

10 Mar 2010

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Discovery Laboratories, Inc. today announces financial results for the fourth quarter ended December 31, 2009 and provides a business update.

10 Mar 2010

Bavarian Nordic' Annual Report 2009

Today Bavarian Nordic published the company's Annual Report 2009. The report is available on the company's website: www.bavarian-nordic.com

10 Mar 2010

Integra LifeSciences releases FDA cleared Total Wrist Fusion System

Integra LifeSciences Holdings Corporation announced today the release of the Integra™ Total Wrist Fusion System, a solution for wrist arthrodesis that is designed to provide fixation of the wrist while decreasing soft tissue irritation. The system provides an optimal balance of compression and stability by combining the Surfix® locking technology and dynamic compression.

10 Mar 2010

FDA clears Oculus Innovative Sciences' Microcyn Skin and Wound HydroGel

Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.

10 Mar 2010

NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

NeoPharm, Inc., announced today that it has filed an orphan drug application with the Office of Orphan Products Development of the United States Food and Drug Administration to have Orphan Drug Designation granted to IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis.

10 Mar 2010

Food News and Research

Great Point and Deerfield invest in BioSante Pharmaceuticals

Evotec completes first-in-human Phase I study of EVT 103 for treatment-resistant depression

Bioness announces two agreements to distribute new devices for patients with neurological impairment

Controlling cholesterol using biologically active molecules isolated from algal infusion

Lotus Pharmaceuticals announces groundbreaking ceremony to construct new building complex in Beijing

Quantum Polymers offers AvaSpire modified PEEK resin based plastic products

Congress works on tariff-lowering legislation for Haiti as Preval meets with U.S. leaders in Washington

Global Food Security: New programme aims at providing sustainable, secure supply of good quality food

QLT announces results from Phase II clinical trials and device study for PPDS

Patients who undergo gastric bypass surgery increase their risk of developing kidney stones

DSPA's lurasidone NDA accepted for FDA review

Biomoda, Obio collaborate to expand Biomoda’s lung cancer screening program for veterans into Ohio

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Bavarian Nordic' Annual Report 2009

Integra LifeSciences releases FDA cleared Total Wrist Fusion System

FDA clears Oculus Innovative Sciences' Microcyn Skin and Wound HydroGel

NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients

European countries to review impact of environmental policies on popluation health status

First Edition: March 10, 2010

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News